.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Acetaminophen (APAP) is a common analgesic in India, yet its overdose frequently leads to drug-induced acute liver failure. Researchers have recently identified cordycepin hepatoprotective effects as a potential therapeutic breakthrough for this clinical challenge. This bioactive compound, sourced from the edible fungus Cordyceps militaris, exhibits powerful antioxidant and anti-inflammatory properties that preserve hepatocyte integrity during toxic metabolic stress.
The study utilized mouse models to investigate how cordycepin pretreatment affects liver recovery after high-dose paracetamol exposure. Specifically, researchers observed that administering this fungal derivative significantly decreased serum transaminase levels, which are critical biomarkers of liver cell death. Furthermore, histological assessments confirmed a marked reduction in hepatic necrosis and a decrease in inflammatory cell infiltration in the treated groups.
Moreover, the underlying mechanism involves the sophisticated regulation of endoplasmic reticulum (ER) proteostasis. Cordycepin appears to coordinate signaling through the HIF-1 and PPAR pathways to maintain cellular equilibrium. Consequently, these cordycepin hepatoprotective effects prevent the programmed cell death of hepatocytes typically triggered by paracetamol metabolites. Unlike conventional single-target therapies, this natural compound offers a multi-faceted approach to preventing chemical-induced organ damage.
Transcriptomic analysis showed that cordycepin successfully reverses the expression of key genes linked to oxidative damage and inflammatory responses. While N-acetylcysteine (NAC) currently serves as the standard clinical antidote, it often faces limitations due to its narrow therapeutic window. Therefore, exploring natural hepatoprotective agents like cordycepin could provide a valuable adjunct for managing acute liver injuries. However, clinicians must wait for robust human clinical trials to define exact dosage requirements and long-term safety profiles.
Cordycepin is a primary bioactive nucleoside found in the medicinal mushroom Cordyceps militaris, which has long been valued for its anti-inflammatory and immune-modulating properties.
It safeguards the liver by mitigating oxidative stress, suppressing pro-inflammatory cytokines, and restoring ER proteostasis to prevent hepatocyte apoptosis.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional healthcare. Always consult a qualified medical professional for diagnosis and treatment. Refer to the latest local and national guidelines for clinical practice.
References
Fu C et al. Edible Fungus Compound Cordycepin Protects Against Acetaminophen-Induced Liver Injury. J Clin Lab Anal. 2026 May 25. doi: 10.1002/jcla.70266. PMID: 42184123.
Ding J et al. Cordycepin Protects against Hepatic Ischemia/Reperfusion Injury via Inhibiting MAPK/NF-κB Pathway. Gastroenterology. 2014;147(4):765-783.
Kaur K et al. To Study Hepatoprotective Potential of Genius Cordyceps. Journal of Advance and Future Research. 2026 May 20;4(5).
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A study demonstrates that cordycepin, a compound from Cordyceps militaris, mitigates acetaminophen-induced liver injury by modulating ER stress pathways....
4 months ago
As monsoon seasons elevate arboviral disease threats, Tamil Nadu has initiated an ICMR-monitored evaluation of the tetravalent dengue vaccine in Tenkasi district. Clinicians emphasize clinical monitoring, public prevention, and high-quality early pediatric care to reduce disease morbidity across endemic regions.
Today
A comparative cohort study evaluates vNOTES vs TLH hysterectomy for benign conditions, demonstrating shorter operative duration, faster return to daily activities, and equivalent female sexual function scores without increased dyspareunia.
Today
Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today
This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today
A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today
